SCHEMBL1024404

SCHEMBL1024404

CN1CCCN(CC(=O)NC2CCCCC2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 1.00
CHRM5 P08912 3/20 0.61
CHRM3 P20309 2/20 0.61
CA12 O43570 2/20 0.61
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
CA9 Q16790 2/20 0.61
ALDH1A1 P00352 4/20 0.57
MAPK1 P28482 1/20 0.57
CHRM1 P11229 2/20 0.55
CHRM2 P08172 1/20 0.55
CHRM4 P08173 1/20 0.55
LMNA P02545 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
KDM4E B2RXH2 1/20 0.50
DRD4 P21917 1/20 0.50
DRD3 P35462 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11010870 0.95 SIGMAR1 (0.91) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL3946291 0.87 SIGMAR1 (0.77) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL16374976 0.87 SIGMAR1 (0.77) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL22236796 0.85 SIGMAR1 (0.74) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL6479844 0.85 SIGMAR1 (0.75) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL15587841 0.85 SIGMAR1 (0.74) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL1555698 0.82 SIGMAR1 (0.76) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL22236822 0.81 SIGMAR1 (0.68) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL19739051 0.81 SIGMAR1 (0.70) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL23612751 0.81 SIGMAR1 (0.71) SIGMAR1CHRM5CHRM3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO claimed
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed